| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,192,223 | 2,035,846 | 2,117,531 | 2,195,661 | | Cost of Revenue | 525,412 | 579,591 | 560,963 | 562,103 | | | Gross Profit | 1,666,811 | 1,456,255 | 1,556,568 | 1,633,558 | | | Operating Expenses | | Research Development | 176,760 | 171,207 | 190,842 | 186,791 | | Selling General and Administrative | 796,275 | 362,569 | 788,931 | 846,482 | | Non Recurring | 86,165 | 49,119 |
-
|
-
| | Others | 54,834 | 419,897 | 52,720 | 54,918 | | | | Total Operating Expenses | 1,114,034 | 1,002,792 |
-
|
-
| | | | Operating Income or Loss | 552,777 | 453,463 | 524,075 | 545,367 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 26,744 | 24,368 | 38,556 | 23,385 | | Earnings Before Interest And Taxes | 579,521 | 477,831 | 562,631 | 568,752 | | Interest Expense |
-
| 4,563 | (11) | 619 | | Income Before Tax | 579,521 | 473,268 | 562,642 | 568,133 | | Income Tax Expense | 119,803 | 106,076 | 70,423 | 107,788 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 459,718 | 367,192 | 492,219 | 460,345 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 459,718 | 367,192 | 492,219 | 460,345 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $459,718 | $367,192 | $492,219 | $460,345 |
|
0.45% Nasdaq 
0.20%
Income Statement
